Gabapentin Tablet
Product Images NDC 82619-145

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 82619-145). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Creekwood Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin-100mg 1000s (Gabapentin 100mg 1000s)

Packaging label for Gabapentin Capsules, USP 100 mg by Creekwood Pharmaceuticals LLC. The label indicates the package contains 1000 capsules, with storage instructions and a barcode. It includes a note for pharmacists to provide a Medication Guide when dispensing and cautions to keep capsules out of children's reach.*

FDA Label Image

Gabapentin-100mg 100s (Gabapentin 100mg 100s)

Label for Gabapentin Capsules, USP 100 mg by Creekwood Pharmaceuticals LLC. The label indicates a bottle containing 100 capsules. It includes storage instructions, dispensing information, and the NDC code 82619-142-01. The label is primarily black and white with blue design elements and the Creekwood logo.*

FDA Label Image

Gabapentin-100mg 500s (Gabapentin 100mg 500s)

Gabapentin Capsules, USP 100 mg oral capsules label from Creekwood Pharmaceuticals LLC. The label indicates 500 capsules per container and includes dosage instructions and storage information. It features the NDC 82619-142-02 and a barcode. The label is designed for prescription use with clear branding and regulatory text.*

FDA Label Image

Gabapentin-300mg 1000s (Gabapentin 300mg 1000s)

Label for Gabapentin Capsules USP, 300 mg strength, in capsule form, with a package count of 1000 capsules. The label indicates the product is prescription-only and is manufactured by Science Pharmaceuticals, Inc. for Creekwood Pharmaceuticals LLC. Storage instructions and dispensing advisories are also visible.*

FDA Label Image

Gabapentin-300mg 100s (Gabapentin 300mg 100s)

Gabapentin Capsules USP 300 mg bottle label from Creekwood Pharmaceuticals LLC. The label states 100 capsules per bottle with usual dosing and storage instructions, barcode, and NDC 82619-143-01. It includes pharmacist guidance and medication safety warnings.*

FDA Label Image

Gabapentin-300mg 500s (Gabapentin 300mg 500s)

Gabapentin Capsules USP 300 mg oral capsule label by Creekwood Pharmaceuticals LLC. The label states 500 capsules per bottle with instructions for storage, dispensing, and usual dosage, including a medication guide advisory. It includes a barcode and regulatory information.*

FDA Label Image

Gabapentin-400mg 100s (Gabapentin 400mg 100s)

Label for Gabapentin Capsules, USP 400 mg by Creekwood Pharmaceuticals LLC. The label states each capsule contains 400 mg of gabapentin and includes 100 capsules per package. Directions mention providing a Medication Guide with dispensing. Storage and dispensing instructions, along with NDC 82619-144-01, are printed near a barcode on the right.*

FDA Label Image

Gabapentin-400mg 500s (Gabapentin 400mg 500s)

Label for Gabapentin Capsules, USP 400 mg by Creekwood Pharmaceuticals LLC. The label indicates 500 capsules per bottle, with directions to provide a Medication Guide to each patient. It includes storage instructions and manufacturer details. The label style features a blue wave design and barcode on the right side.*

FDA Label Image

Gabapentin-600mg 100s (Gabapentin 600mg 100s)

Gabapentin Tablets USP 600 mg oral tablets label from Creekwood Pharmaceuticals LLC. The label states this package contains 100 tablets and provides dispensing instructions for pharmacists. It includes storage information, dosage instructions, and a barcode. The product is prescription only (Rx Only).*

FDA Label Image

Gabapentin-600mg 500s (Gabapentin 600mg 500s)

Gabapentin Tablets USP 600 mg oral tablets packaging label by Creekwood Pharmaceuticals LLC. The label indicates a bottle size of 500 tablets and includes storage instructions and prescribing information. The NDC code 82619-145-02 is visible along with a barcode.*

FDA Label Image

Gabapentin-800mg 100s (Gabapentin 800mg 100s)

Label for Gabapentin Tablets, USP 800 mg oral tablets by Creekwood Pharmaceuticals LLC. The label indicates a count of 100 tablets and includes dosage and storage information. It features the Creekwood logo and an NDC code 82619-146-01, with instructions for pharmacists to provide a medication guide to patients.*

FDA Label Image

Gabapentin-800mg 500s (Gabapentin 800mg 500s)

Label for Gabapentin Tablets, USP 800 mg oral tablets by Creekwood Pharmaceuticals LLC. The label indicates a bottle containing 500 tablets with prescription-only status. It includes storage instructions, usual dosage guidance, and a pharmacist medication guide note. The label features a barcode and the Creekwood logo.*

FDA Label Image

Figure 1 (Image 01)

A line graph showing the mean pain score over 8 weeks for two groups: placebo and gabapentin 3600 mg/day. The x-axis represents weeks from baseline to week 8, with a marked 4-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain scores ranging from 0 to 10. The gabapentin group's pain score decreases steadily over the study period, while the placebo group's pain score remains relatively stable.*

FDA Label Image

Figure 2 (Image 02)

A line graph displaying mean pain score over a 7-week period comparing Placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The x-axis represents weeks from baseline to week 7, with a 3-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain score from 0 to 10, illustrating pain score trends for each treatment group over time.*

FDA Label Image

Figure 3 (Image 03)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and Gabapentin (GBP) doses in two studies. The chart shows percentages of responders with GBP doses 3600 mg, 1800 mg, and 2400 mg demonstrating higher responder rates than placebo, indicated with statistical significance markers.*

FDA Label Image

Image-04 (Image 04)

A mathematical formula for calculating Creatinine Clearance (CLCr), showing variables including age in years, weight in kilograms, serum creatinine level in mg/dL, and an adjustment factor of 0.85 for female patients.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure diagram of Gabapentin, showing its cyclohexane ring attached to an amino group and a carboxylic acid group.*

FDA Label Image

Image-09 (Image 09)

A scatter plot showing the percentage difference versus daily dose in milligrams for Gabapentin. The chart includes data points from three studies labeled as Study a, Study b, and Study c, plotted at daily doses of approximately 600 mg, 900 mg, 1200 mg, and 1800 mg.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.